Xenon Pharmaceuticals Announces Pricing Of Upsized $650.0 Million Public Offering
ReutersMar 11, 2026 2:41 AM
March 10 (Reuters) - Xenon Pharmaceuticals Inc XENE.O:
XENON PHARMACEUTICALS ANNOUNCES PRICING OF UPSIZED $650.0 MILLION PUBLIC OFFERING
XENON PHARMACEUTICALS INC - COMMON SHARES OFFERED AT $57.00 PER SHARE; PRE-FUNDED WARRANTS AT $56.9999
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
CRCL Beyond $100: Decoding the Forces Behind Circle’s 100% Rally and the Quest for $300
Circle leads crypto stocks, surging 107% over the past month to $110 and entering a critical zone.TradingKey
21 hours ago
Micron vs. Samsung vs. SK Hynix: Is MU Stock the Best Memory Stock for 2026?
TradingKey - Relying on strong AI demand, more memory per system, and sluggish supply response, 2026 will be the memory cycle. Micron Technology (MU) is now in an excellent competitive position today with HBM3E and looking to ramp HBM4E into Nvidia’s Vera Rubin platforms in the second half of 2026.TradingKey
22 hours ago
Nvidia GTC 2026 Preview: Two Major Architectures Launch Together, Can They Solve the AI Anxiety Dilemma?
TradingKey - NVIDIA (NVDA) GTC 2026, the world's most anticipated annual event in the global AI computing sector, will take place from March 16 to 19.TradingKey
Sun, Mar 8
